Palbociclib Capsules Exporter from India | Genliva Wellness LLP Oncology Pharma Manufacturer

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Palbociclib Capsules are a selective CDK4/6 inhibitor used in the treatment of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer. It works by inhibiting cyclin-dependent kinases (CDK4 and CDK6), thereby slowing cancer cell division and tumor progression.

Genliva Wellness LLP is a trusted Palbociclib capsule exporter from India, offering high-quality targeted oncology formulations for international markets. As a pharma contract manufacturer and third party manufacturing company in India, Genliva supplies oncology medicines to distributors, hospitals, and importers with a strong focus on quality, compliance, and consistent export supply.

Palbociclib capsules are an advanced targeted therapy formulated to block CDK 4/6 activity, thereby controlling abnormal cell division in cancer. The formulation is developed for precision treatment and consistent therapeutic performance in oncology care.

Targets CDK 4/6 pathways to inhibit tumor cell proliferation
Supports cell cycle arrest at the G1 phase
Commonly used alongside endocrine therapy for enhanced effectiveness
Ensures reliable bioavailability and therapeutic consistency
Developed under strict international quality and compliance standards
Suitable for specialized oncology treatment regimens

This product is indicated for the management of certain types of advanced breast cancer, particularly where hormone receptors are involved. It plays a key role in combination therapy to improve clinical outcomes.

Hormone receptor-positive (HR+), HER2-negative advanced breast cancer
Metastatic breast cancer treatment protocols
Combination therapy with aromatase inhibitors
Used with fulvestrant in progressive disease conditions
Helps in delaying tumor progression and improving disease control

Capsules are well-suited for oncology medications requiring precision and stability. They offer flexibility in formulation and ease of administration for long-term treatment plans.

Delivers precise and uniform dosing
Smooth swallowing and better patient acceptability
Protects sensitive active ingredients from degradation
Adaptable for complex or low-dose formulations
Maintains product stability during storage and transport
Convenient for packaging and global supply chains